Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (1-10 of 508) with videos related to

Pageof 51
Sort By:
Clinical Trials (London, England)|November 13, 2014
Commentary on VickersColin McCowan, Ian Ford
Statistics in Medicine|September 27, 2002
The role of covariates in estimating treatment effects and risk in long-term clinical trialsIan Ford, John Norrie
The New England Journal of Medicine|August 13, 2016
Pragmatic TrialsIan Ford, John Norrie
Current Opinion in Lipidology|January 19, 2016
Long-term follow-up of lipid-lowering trialsChris J Packard, Ian Ford
Journal of the American Society of Nephrology : JASN|July 2, 2020
Authors' ReplyIain C Macdougall, Ian Ford
The New England Journal of Medicine|June 13, 2019
Intravenous Iron and Maintenance Hemodialysis. ReplyIain C Macdougall, Ian Ford
Heart (British Cardiac Society)|April 4, 2025
Iron deficiency in patients with atrial fibrillation: moving towards a treatment target?Paul R Kalra, Ian Ford
European Journal of Heart Failure|August 9, 2002
The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?Jan Erik Otterstad, Ian Ford
Lancet (London, England)|May 6, 2023
Unanswered questions from the IRONMAN trial - Authors' replyIan Ford, Paul R Kalra
Biometrical Journal. Biometrische Zeitschrift|July 12, 2007
A partial likelihood approach to smooth estimation of dynamic covariate effects using penalised splinesDenise Brown, Göran Kauermann, Ian Ford
Pageof 51

Showing results (1-10 of 508) with videos related to

Sort By:
Pageof 51
Clinical Trials (London, England)|November 13, 2014
Commentary on VickersColin McCowan, Ian Ford
Statistics in Medicine|September 27, 2002
The role of covariates in estimating treatment effects and risk in long-term clinical trialsIan Ford, John Norrie
The New England Journal of Medicine|August 13, 2016
Pragmatic TrialsIan Ford, John Norrie
Current Opinion in Lipidology|January 19, 2016
Long-term follow-up of lipid-lowering trialsChris J Packard, Ian Ford
Journal of the American Society of Nephrology : JASN|July 2, 2020
Authors' ReplyIain C Macdougall, Ian Ford
The New England Journal of Medicine|June 13, 2019
Intravenous Iron and Maintenance Hemodialysis. ReplyIain C Macdougall, Ian Ford
Heart (British Cardiac Society)|April 4, 2025
Iron deficiency in patients with atrial fibrillation: moving towards a treatment target?Paul R Kalra, Ian Ford
European Journal of Heart Failure|August 9, 2002
The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?Jan Erik Otterstad, Ian Ford
Lancet (London, England)|May 6, 2023
Unanswered questions from the IRONMAN trial - Authors' replyIan Ford, Paul R Kalra
Biometrical Journal. Biometrische Zeitschrift|July 12, 2007
A partial likelihood approach to smooth estimation of dynamic covariate effects using penalised splinesDenise Brown, Göran Kauermann, Ian Ford
Pageof 51